Brain Health in Midlife
N/A
Completed
NCT06640842
| Condition | Brain Health, Gestational Hypertension, Alzheimer Disease, Dementia |
|---|
| Phase | N/A |
|---|
| Sponsor | University of Kansas Medical Center |
|---|
| Status | Completed |
|---|
| Enrollment | 24 participants |
|---|
| Interventions | A combination of various tests and biomarkers will be completed to understand the effect of hypertensive disorders of pregnancy on brain health in midlife. |
|---|
| Start date | Sep 23, 2024 |
|---|
| Completion date | Jun 13, 2025 |
|---|
| Results posted | Jul 14, 2026 |
|---|
Summary
The purpose of this study is to learn if hypertensive disorders during pregnancy affects brain health in midlife.
Cardiometabolic Biomarkers - Glucose & Lipids
Baseline · mg/dL
| Hypertensive Disorder of Pregnancy | 93.25 ± 15.71 mg/dL |
|---|
| Healthy Pregnancy | 94.50 ± 13.53 mg/dL |
|---|
| Hypertensive Disorder of Pregnancy | 170 ± 38.69 mg/dL |
|---|
| Healthy Pregnancy | 172.50 ± 28.27 mg/dL |
|---|
| Hypertensive Disorder of Pregnancy | 92.58 ± 32.81 mg/dL |
|---|
| Healthy Pregnancy | 132.42 ± 83.07 mg/dL |
|---|
Cardiometabolic Biomarkers - Insulin
Baseline · uIU/mL
| Hypertensive Disorder of Pregnancy | 7.44 ± 3.63 uIU/mL |
|---|
| Healthy Pregnancy | 14.13 ± 12.97 uIU/mL |
|---|
Cardiometabolic Biomarkers - Hemoglobin A1C
Baseline · percentage of glycated hemoglobin
| Hypertensive Disorder of Pregnancy | 5.72 ± 1.09 percentage of glycated hemoglobin |
|---|
| Healthy Pregnancy | 5.45 ± 0.34 percentage of glycated hemoglobin |
|---|
Open in BENITIONS
View on ClinicalTrials.gov
Other trials for this condition
All trials
This page summarises publicly available data from ClinicalTrials.gov. It is not medical advice and not investment advice. Always consult a qualified healthcare professional.